Showing 1 - 10 of 20
Persistent link: https://www.econbiz.de/10005478576
Persistent link: https://www.econbiz.de/10005389007
The U.S. pharmaceutical industry has experienced in recent years two dramatic changes: stagnation in the growth of new molecular entities approved for marketing, and a wave of mergers linking inter alia some of the largest companies. This paper explores possible links between these two phenomena...
Persistent link: https://www.econbiz.de/10011139840
To understand the issues involved, leading lawyers and economists examine various facets of the child support system from a law and economics perspective. They consider the incentives faced by both custodial and non-custodial parents, and search for policy actions that are more...
Persistent link: https://www.econbiz.de/10011159818
To understand the issues involved, leading lawyers and economists examine various facets of the child support system from a law and economics perspective. They consider the incentives faced by both custodial and non-custodial parents, and search for policy actions that are more...
Persistent link: https://www.econbiz.de/10011159834
By weaving together the fields of health economics, industrial organisation and industrial development, this book describes the benefits of promoting a country’s health industry as a way of stimulating its high-technology industrial capacity. The authors illustrate that the development of...
Persistent link: https://www.econbiz.de/10011169343
Pharmaceutical Economics encompasses the economics of the pharmaceutical industry but it is far more than that. Because pharmaceuticals have an important impact on public health, government actions are necessarily involved, which have a major effect on market outcomes. An important example is...
Persistent link: https://www.econbiz.de/10010764264
Conflicting trends confound the pharmaceutical industry. The productivity of pharmaceutical innovation has declined in recent years. At the same time, the cohort of large companies who are the leading engines of pharmaceutical R&D has become increasingly concentrated. The concurrent presence of...
Persistent link: https://www.econbiz.de/10010870797
Persistent link: https://www.econbiz.de/10010843441
The U.S. pharmaceutical industry has experienced in recent years two dramatic changes: stagnation in the growth of new molecular entities approved for marketing, and a wave of mergers linking inter alia some of the largest companies. This paper explores possible links between these two phenomena...
Persistent link: https://www.econbiz.de/10009369406